Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Healius Limited ( (AU:HLS) ).
Healius Limited has released its full-year results for FY 2025, highlighting the company’s financial performance and business prospects. The announcement includes insights into potential risks and uncertainties that could impact future results, such as regulatory decisions, competitive changes, and cost fluctuations, which are crucial for stakeholders to consider.
The most recent analyst rating on (AU:HLS) stock is a Sell with a A$0.71 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited is a company operating in the healthcare industry, focusing on providing medical and healthcare services. The company is involved in various healthcare operations, which may include diagnostic services, medical centers, and pathology services, catering to a wide range of healthcare needs.
Average Trading Volume: 5,367,552
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$584.5M
See more data about HLS stock on TipRanks’ Stock Analysis page.